- Monica-Emilia Chirilă1, Alessio Giuseppe Morganti2,3
1 Mvision AI, Helsinki, Finland
2 Radiation Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, 40138 Bologna, Italy.
3Radiation Oncology, Department of Experimental, Diagnostic and Specialty Medicine, Alma Mater Studiorum University of Bologna, 40138 Bologna, Italy.
Corresponding author: Monica Emilia Chirilă, Email: email@example.com
Published: Volume II, Issue 2, December 2022, 66-69, , , - DOI: 10.53011/JMRO.2022.02.10
Professor Alessio Giuseppe Morganti teaches at the University “Alma Mater Studiorum” from Bologna. He is an expert in radiotherapy of prostate cancer and of gastrointestinal malignancies (rectal, pancreatic and biliary tract cancers), and also in palliative care. He was the principal investigator in more than 50 clinical studies and published more than 400 papers in Scopus- indexed journals.
He kindly accepted to share his view about current aspects of Radiation Oncology.